Results 161 to 170 of about 113,903 (250)

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real‐World, Monocentric, Observational Study and Critical Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig, Lennert Sitzmann, Doreen Hartenstein, Marion Labisch, Chi Wang Ip, Jens Volkmann, Christine Daniels   +6 more
wiley   +1 more source

Cognitive profiles in older adults with psychotic disorders: Results from routine clinical assessments. [PDF]

Schizophr Res Cogn
Nait Abbou I, Maheu-Savard C, Chalifoux F, Roy-Desruisseaux J, Trudel JF, Maltais JR.   +5 more
europepmc   +1 more source

The Frequency of Psychotic Disorders Since the Legalization of Cannabis in Germany: A Before-and-After Analysis. [PDF]

Dtsch Arztebl Int
Greiner SK, Jäger M, Schmauß V, Schneider-Axmann T, Frasch K, Steber R, Hasan A.   +6 more
europepmc   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz, Marina Farah, Laura Silveira‐Moriyama   +2 more
wiley   +1 more source

Association between loneliness and hippocampal responses to dynamic social stimuli in psychotic disorders. [PDF]

Psychol Med
McKenna F, Vinke LN, de Marneffe F, Avananki M, Holt DJ.   +4 more
europepmc   +1 more source

Dopamine and Mood in Psychotic Disorders: An 18F-DOPA PET Study. [PDF]

JAMA Psychiatry
Jauhar S, McCutcheon RA, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Whitehurst T, Arumuham A, Onwordi E, Turkheimer F, McGuire P, Young AH, Howes OD.   +13 more
europepmc   +1 more source

High Prevalence and Clinical Impact of Fibromyalgia in Functional Motor Disorder

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Fibromyalgia is characterized by widespread pain, fatigue, sleep and cognitive symptoms. It overlaps clinically with functional motor disorder (FMD), yet its prevalence and impact in FMD remain uncertain. Objective To determine the prevalence of fibromyalgia in FMD using the current criteria and evaluate its effects on motor ...
Tereza Serranová, Lucia Nováková, Martin Jirásek, Barbora Křupková, Evžen Růžička, Michele Tinazzi, Tomáš Sieger   +6 more
wiley   +1 more source

Fetal Head Growth and Head Circumference at Birth in Children of Women with Psychotic Disorders and Population-Based Controls. [PDF]

Schizophr Bull
van Houtum LAEM, Koc D, Grundeman SA, Duvekot HJ, El Marroun H, van Haren NEM, Bijma HH.   +6 more
europepmc   +1 more source

Apathy in Parkinson's Disease: Distinguishing Overlapping Symptoms Via Network Analysis

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Anxiety, fatigue, and excessive daytime sleepiness (EDS) frequently co‐occur in Parkinson's disease (PD) and can influence the clinical determination of apathy. Objective To distinguish patient‐reported apathy from other non‐motor symptoms.
Joseph Seemiller, Abhimanyu Mahajan, Christopher B. Morrow, Joseph F. McGuire, Dawn Bowers, Kelly A. Mills, Gregory M. Pontone   +6 more
wiley   +1 more source